Begin With the End in Mind: Are You Ready for First-in-Human Clinical Trials?

You’ve been moving steadily from discovery into preclinical, and based on the data, your molecule will be advancing into First-in-Human clinical trials. But with funds limited, resources tight and many conflicting priorities, how do you know where to begin to make sure your organization is ready for clinical trials?

Watch our presentation moderated by Aperio COO Suzanne Kincaid along with her distinguished line-up of panelists from Nuventra Pharma Sciences, SpringWorks Therapeutics and G1 Therapeutics to learn what your organization needs to do to prepare for First-in-Human.

Watch

YOU MAY ALSO BE INTERESTED IN

BLOG

Stay educated on industry trends. Get started. 

ARTICLE

Top 5 Considerations for
FIH Clinical Trials

WEBCAST

Clinical Outsourcing: Building CRO Partnerships